Activation of the noradrenaline transporter gene using the radiation-inducible WAF1-1 promoter sensitizes tumour cells to [I-131] MIBG targeted radiotherapy
Tools
McCluskey, A. G. and Mairs, R. J. and Robson, T. and Hirst, D. G. and Boyd, M. (2012) Activation of the noradrenaline transporter gene using the radiation-inducible WAF1-1 promoter sensitizes tumour cells to [I-131] MIBG targeted radiotherapy. Mutagenesis, 27 (1). p. 131. 82. ISSN 0267-8357 (https://doi.org/10.1093/mutage/ger068)
Full text not available in this repository.Request a copyAbstract
Radiotherapy given in combination with gene transfer is a promising approach for the treatment of cancer. However, progress in this field depends upon achieving the selective expression of therapeutic transgenes in tumours. Therefore, radiation-inducible gene promoters have attracted interest because they may enable temporal and spatial gene activation.
ORCID iDs
McCluskey, A. G. ORCID: https://orcid.org/0000-0002-2249-1854, Mairs, R. J., Robson, T., Hirst, D. G. and Boyd, M. ORCID: https://orcid.org/0000-0003-4120-2218;-
-
Item type: Article ID code: 40162 Dates: DateEvent2012PublishedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Technology and Innovation Centre > Advanced Science and Technology
Technology and Innovation Centre > BionanotechnologyDepositing user: Pure Administrator Date deposited: 22 Jun 2012 08:29 Last modified: 11 Nov 2024 10:09 URI: https://strathprints.strath.ac.uk/id/eprint/40162
CORE (COnnecting REpositories)